​With the rise of digital technology in healthcare and the growing number of connected devices, a significant portion of health data now comes from digital care pathways. It is generating an unprecedented volume of real-world health data, becoming essential for optimization, research, and innovation. However, its secondary use presents complex ethical, regulatory, and business challenges for all stakeholders.

​

This report aims to provide a better understanding of the issues, risks, uses, and prospects linked to the secondary use of health data from digital devices.

​

Strategic Value

How can pharmaceutical companies transform digital medical device data into actionable insights for R&D?

What are the concrete opportunities for leveraging digital health data in post-market studies?

​

Regulatory & Implementation

What is the evolving regulatory landscape for secondary use of health data across major markets?

How can organizations ensure compliance while maintaining data utility?

​

Future Opportunities:

Which emerging technologies will reshape digital health data utilization?

What partnership models are proving most successful in the digital health ecosystem?

How are leading companies integrating digital health data into their development pipelines